Autopsy report · NCT01842282
Amlexanox for Type 2 Diabetes and Obesity
Cause of deathFunding or business, also staffing, sites or logistics
“Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 7 months before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 9 years 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes Mellitus Type 2; Non Alcoholic Fatty Liver Disease; Obesity
- Interventions
- Amlexanox
- Participants
- 7
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
“Suspended because the lack of patients among the time this clinical trial was running.” - A Study Of PF-06664178 In Patients With Advanced Solid Tumors
“The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.” - BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
“Company was sold and clinical trial was suspended then teminated” - Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
“The clinical trial has been terminated due to the revocation of funding. Although one subject was enrolled, the participant withdrew prior to receiving any treatment. No trial-related procedures generating evaluable clinical data were performed.” - Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
“Study has been suspended due to clinical hold.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.